BLB&B Advisors’s Teva Pharmaceuticals TEVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-18,996
Closed -$334K 315
2017
Q3
$334K Sell
18,996
-8,910
-32% -$200K 0.05% 215
2017
Q2
$927K Buy
27,906
+674
+2% +$20.9K 0.15% 130
2017
Q1
$874K Buy
27,232
+650
+2% +$22.2K 0.15% 132
2016
Q4
$964K Sell
26,582
-521
-2% -$20.8K 0.17% 127
2016
Q3
$1.25M Buy
27,103
+1,128
+4% +$58.9K 0.23% 106
2016
Q2
$1.3M Sell
25,975
-3
-0% -$160 0.25% 101
2016
Q1
$1.39M Buy
25,978
+302
+1% +$17.7K 0.28% 96
2015
Q4
$1.69M Sell
25,676
-898
-3% -$55.5K 0.36% 83
2015
Q3
$1.5M Sell
26,574
-4,281
-14% -$278K 0.33% 88
2015
Q2
$1.82M Sell
30,855
-1,220
-4% -$75.3K 0.38% 80
2015
Q1
$2M Buy
32,075
+1,203
+4% +$69.9K 0.42% 72
2014
Q4
$1.77M Buy
30,872
+202
+0.7% +$11.3K 0.38% 72
2014
Q3
$1.65M Sell
30,670
-67
-0.2% -$3.55K 0.36% 75
2014
Q2
$1.61M Sell
30,737
-100
-0.3% -$5.11K 0.34% 75
2014
Q1
$1.63M Sell
30,837
-100
-0.3% -$4.62K 0.36% 72
2013
Q4
$1.24M Sell
30,937
-254
-0.8% -$10K 0.3% 85
2013
Q3
$1.18M Buy
31,191
+497
+2% +$19.4K 0.31% 81
2013
Q2
$1.2M Buy
+30,694
New +$1.2M 0.33% 80

Other funds holding TEVA